A case study: consequences of ANTI-TNFα therapy and foot ulcerations. A patient with Ankylosing Spondylitis (AS) treated with Infliximab

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1757-1146

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: A case study: consequences of ANTI-TNFα therapy and foot ulcerations. A patient with Ankylosing Spondylitis (AS) treated with Infliximab ; volume:3 ; number:1 ; day:20 ; month:12 ; year:2010 ; pages:1 ; date:12.2010
Journal of foot and ankle research ; 3, Heft 1 (20.12.2010), 1, 12.2010

Creator: Edgson, Lucy

Contributor: Field, Robert
Westlake, Sarah
SpringerLink (Online service)

DOI: 10.1186/1757-1146-3-S1-P6

URN: urn:nbn:de:1111-2016072628228

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:02 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Edgson, Lucy
Field, Robert
Westlake, Sarah
SpringerLink (Online service)

Other Objects (12)

Infliximab-induced retrobulbar optic neuritis in a patient with ankylosing spondylitis

Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab

Infliximab in ankylosing spondylitis: alone or in combination with methotrexate? A pharmacokinetic comparative study

Body mass index influences the response to infliximab in ankylosing spondylitis

Treatment of ankylosing spondylitis with TNFα inhibitors does not affect serum levels of tryptophan metabolites

ANKHvariants associated with ankylosing spondylitis: gender differences

Atherosclerosis in Egyptian patients with ankylosing spondylitis

Age determines response to anti-TNFα treatment in patients with ankylosing spondylitis and is related to TNFα-producing CD8 cells

Autoimmune inner ear disease associated with ankylosing spondylitis

Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab

Influence of a polymorphism IL1B gene in the response of rheumatoid arthritis and ankylosing spondylitis patients treated with infliximab

Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT)

Infliximab-induced retrobulbar optic neuritis in a patient with ankylosing spondylitis

Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab

Infliximab in ankylosing spondylitis: alone or in combination with methotrexate? A pharmacokinetic comparative study

Body mass index influences the response to infliximab in ankylosing spondylitis

Treatment of ankylosing spondylitis with TNFα inhibitors does not affect serum levels of tryptophan metabolites

ANKHvariants associated with ankylosing spondylitis: gender differences

Atherosclerosis in Egyptian patients with ankylosing spondylitis

Age determines response to anti-TNFα treatment in patients with ankylosing spondylitis and is related to TNFα-producing CD8 cells

Autoimmune inner ear disease associated with ankylosing spondylitis

Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab

Influence of a polymorphism IL1B gene in the response of rheumatoid arthritis and ankylosing spondylitis patients treated with infliximab

Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT)

Infliximab-induced retrobulbar optic neuritis in a patient with ankylosing spondylitis

Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab

Infliximab in ankylosing spondylitis: alone or in combination with methotrexate? A pharmacokinetic comparative study

Body mass index influences the response to infliximab in ankylosing spondylitis

Treatment of ankylosing spondylitis with TNFα inhibitors does not affect serum levels of tryptophan metabolites

ANKHvariants associated with ankylosing spondylitis: gender differences

Atherosclerosis in Egyptian patients with ankylosing spondylitis

Age determines response to anti-TNFα treatment in patients with ankylosing spondylitis and is related to TNFα-producing CD8 cells

Autoimmune inner ear disease associated with ankylosing spondylitis

Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab

Influence of a polymorphism IL1B gene in the response of rheumatoid arthritis and ankylosing spondylitis patients treated with infliximab

Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT)

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

A case study: consequences of ANTI-TNFα therapy and foot ulcerations. A patient with Ankylosing Spondylitis (AS) treated with Infliximab

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Infliximab-induced retrobulbar optic neuritis in a patient with ankylosing spondylitis

Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab

Infliximab in ankylosing spondylitis: alone or in combination with methotrexate? A pharmacokinetic comparative study

Body mass index influences the response to infliximab in ankylosing spondylitis

Treatment of ankylosing spondylitis with TNFα inhibitors does not affect serum levels of tryptophan metabolites

ANKHvariants associated with ankylosing spondylitis: gender differences

Atherosclerosis in Egyptian patients with ankylosing spondylitis

Age determines response to anti-TNFα treatment in patients with ankylosing spondylitis and is related to TNFα-producing CD8 cells

Autoimmune inner ear disease associated with ankylosing spondylitis

Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab

Influence of a polymorphism IL1B gene in the response of rheumatoid arthritis and ankylosing spondylitis patients treated with infliximab

Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT)

Infliximab-induced retrobulbar optic neuritis in a patient with ankylosing spondylitis

Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab

Infliximab in ankylosing spondylitis: alone or in combination with methotrexate? A pharmacokinetic comparative study

Body mass index influences the response to infliximab in ankylosing spondylitis

Treatment of ankylosing spondylitis with TNFα inhibitors does not affect serum levels of tryptophan metabolites

ANKHvariants associated with ankylosing spondylitis: gender differences

Atherosclerosis in Egyptian patients with ankylosing spondylitis

Age determines response to anti-TNFα treatment in patients with ankylosing spondylitis and is related to TNFα-producing CD8 cells

Autoimmune inner ear disease associated with ankylosing spondylitis

Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab

Influence of a polymorphism IL1B gene in the response of rheumatoid arthritis and ankylosing spondylitis patients treated with infliximab

Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT)

Infliximab-induced retrobulbar optic neuritis in a patient with ankylosing spondylitis

Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab

Infliximab in ankylosing spondylitis: alone or in combination with methotrexate? A pharmacokinetic comparative study

Body mass index influences the response to infliximab in ankylosing spondylitis

Treatment of ankylosing spondylitis with TNFα inhibitors does not affect serum levels of tryptophan metabolites

ANKHvariants associated with ankylosing spondylitis: gender differences

Atherosclerosis in Egyptian patients with ankylosing spondylitis

Age determines response to anti-TNFα treatment in patients with ankylosing spondylitis and is related to TNFα-producing CD8 cells

Autoimmune inner ear disease associated with ankylosing spondylitis

Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab

Influence of a polymorphism IL1B gene in the response of rheumatoid arthritis and ankylosing spondylitis patients treated with infliximab

Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT)

Related objects

Reset password